Vishnu Chemicals Limited (VISHNU)
Investor Presentation on Q1FY27 Financial Results is enclosed.
AI summary
- Q1FY27 operating revenues 433.4 Cr +24.9% y-y; PAT 39.6 Cr +23.0% y-y
- Robust growth driven by strong execution, operational resilience, and strategic integration
- Balanced revenue mix with 45:55 domestic-to-export split, demand from 50+ countries
- Strategic expansions in chromium, barium, strontium chemicals and backward integration underway
- Planned solar capacity addition of ~20 MW to reduce power costs and support sustainability
- Management expects sustainable medium-term growth supported by multiple expansions
- Global macro challenges include West Asia crisis and elevated ocean freight costs
- Consistent dividend track record with 15% dividend proposed for FY26 (subject to approval)
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 VISHNU — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add VISHNU to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Vishnu Chemicals Limited
Important.
The summary above is generated automatically from Vishnu Chemicals Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.